Related Experiment Video
Updated: Jun 5, 2025

Author Spotlight: Exploring the Complexities of Achilles Tendon Injuries — Research and Future Directions
Published on: October 27, 2023
Validity and Reliability of the Turkish Version of the Medial Tibial Stress Syndrome Score
Merve Demir Benli1, Marinus Winters2, Aynur S Arslan3
1Department of Sports Medicine, Faculty of Medicine, Dokuz Eylül University, Balçova, İzmir, Turkey.
Background:
Medial tibial stress syndrome (MTSS) is a common leg injury in military personnel and athletes and is especially related to running and jumping. A patient-reported outcome measure, the MTSS score, was developed to determine the severity of MTSS.
Purpose:
To translate, culturally adapt, and validate the MTSS score for the Turkish language.
Study Design:
Cohort study (diagnosis); Level of evidence, 2.
Methods:
Established guidelines were used for translation and adaptation. The Turkish version of the MTSS (MTSS-Tr) score was completed twice with a 1-week interval between assessments. In the first assessment, patients also completed the Turkish version of the 36-Item Short-Form Survey (SF-36-Tr) and a visual analog scale (VAS) for pain. Test-retest reliability and internal consistency of the MTSS-Tr were measured with the intraclass correlation coefficient (ICC) and Cronbach α coefficient, respectively. The construct validity was demonstrated with the Spearman correlation coefficient (r S).
Results:
A total of 48 participants were included in the study. The test-retest reliability was good and internal consistency was good (ICC, 0.9; Cronbach α, 0.884). The MTSS-Tr score was highly negatively correlated with the physical component score of the SF-36-Tr (r S = -0.716; P < .001). There was a moderate correlation between the MTSS-Tr score and the VAS pain score (r S = 0.465; P = .001).
Conclusion:
The translated MTSS-Tr score has good internal consistency and good reliability and validity. Therefore, the MTSS-Tr score is useful to evaluate symptoms in patients with MTSS.
Registration:
NCT05400668 (ClinicalTrials.gov identifier).

